Apellis Pharmaceuticals (APLS) EBITDA

Price: $19.97
Market Cap: $2.51B
Avg Volume: 1.92M
Country: US
Industry: Biotechnology
Sector: Healthcare
Beta: 0.844
52W Range: $19.755-57.85
Website: Apellis Pharmaceuticals

What is Apellis Pharmaceuticals's EBITDA?

  • Apellis Pharmaceuticals's annual EBITDA is $-236.39M.
  • Apellis Pharmaceuticals's quarterly EBITDA is $-24.08M.

What is EBITDA?

EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is a measure of a company's overall financial performance and is used as an alternative to net income in some circumstances.

How is EBITDA calculated?

EBITDA is calculated using the following formula:

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Related Metrics

Other important metrics to assess Apellis Pharmaceuticals's financial health include:

  • EBITDA Ratio - measures the company's EBITDA as a percentage of its revenue:
    • Annual: -33.30%
    • Quarterly: -11.33%
  • Growth EBITDA - measures the annual growth rate of the company's EBITDA:
    • Annual: 52.26%
    • Quarterly: 45.11%
  • Growth EBITDA Ratio - measures the annual growth rate of the company's EBITDA ratio:
    • Annual: 73.33%
    • Quarterly: 49.16%

These metrics provide insights into Apellis Pharmaceuticals's financial health and its ability to meet short-term obligations. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.

Annual EBITDA

$-236.39M

Quarterly EBITDA

$-24.08M

Apellis Pharmaceuticals Historical EBITDA
Historical EBITDA Ratio (Annual)
Historical EBITDA Ratio (Quarterly)

Apellis Pharmaceuticals Historical EBITDA Metrics

The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2024.

Year EBITDA Growth EBITDA EBITDA Ratio Growth EBITDA Ratio
2024 $-236.39M 52.26% -33.30% 73.33%
2023 $-495.21M 19.79% -124.87% 84.75%
2022 $-617.39M 15.57% -818.58% -2.28%
2021 $-731.27M -134.21% -1098.61% -858.36%
2020 $-312.23M -4.49% -124.57% 0.00%
2019 $-298.83M 0.00% - 0.00%
2018 $- 100.00% 0.00% 0.00%
2017 $-50.90M -32372.68% - 0.00%
2016 $157.71K -97.54% - 0.00%
2015 $6.40M 156.69% - 0.00%

Related Metrics

Explore detailed financial metrics and analysis for APLS.

Financial Analysis
Financial Statements Stock Forecast Price Target Technical Analysis Stock Splits Employee Count
Company Intelligence
Ownership Insider Trading SEC Filings Congress Trading News Earnings Call Transcripts
Income & Revenue
Earnings Revenue Revenue Growth Profit Net Income Profit Margin EBITDA Free Cash Flow Revenue Segments
Valuation
Valuation Market Cap Enterprise Value P/E Ratio PEG Ratio P/S Ratio P/B Ratio Book Value
Returns & Ratios
ROIC ROE ROA Current Ratio Quick Ratio Debt/Equity Ratio Earnings Per Share
Balance Sheet
Assets Debt Cash On Hand Shares Outstanding
Dividends
Dividends Dividend Yield Payout Ratio